Successful patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury
Neuroplast, a Dutch clinical-stage biotech, focusing on cell-based treatments for neurodegenerative diseases, has Injury (TSCI). Preliminary data indicate an excellent…